Gökhan Okan1, Adile Merve Baki2, Eda Yorulmaz3, Semra Doğru-Abbasoğlu2, Pervin Vural2. 1. Dermatology Department, Kemerburgaz University, Istanbul. 2. Istanbul Faculty of Medicine, Department of Biochemistry, Istanbul University, Istanbul. 3. Department of Biochemistry, Medical Park Bahçelievler Hospital, Istanbul.
Abstract
BACKGROUND: Psoriasis is a chronic immune-mediated inflammatory skin disease associated with increase of some pro-inflammatory mediators. We wanted to investigate whether there is a relationship between psoriasis and visfatin, fetuin-A and pentraxin 3 (PTX3)-pro-inflammatory mediators implicated in the development of insulin resistance (IR), metabolic syndrome, and atherosclerosis. METHODS: Visfatin, fetuin-A, and PTX3 concentrations were measured in 45 patients with plaque-type psoriasis and 45 healthy controls using enzyme-linked immunosorbent assay (ELISA). RESULTS: Serum levels of visfatin, fetuin-A, and PTX3 in patients with psoriasis were found to be higher than in healthy controls (P = 0.002, P = 0.009, P < 0.001, respectively). Psoriasis area and severity index (PASI) score correlated significantly with visfatin and fetuin-A levels (P = 0.011, P = 0.040, respectively). There was a significant positive correlation between visfatin and fetuin-A (P < 0.001). PTX3 levels were correlated positively with homeostasis model assessment (HOMA-IR), insulin, triglyceride (TG), and very low density lipoprotein cholesterol (VLDL; P = 0.009, P = 0.007, P = 0.023, P = 0.024, respectively). CONCLUSIONS: Increased serum visfatin, fetuin-A, and PTX3 levels, and the presence of positive correlation between visfatin, fetuin-A, and PASI score, probably reflect the inflammatory state and IR seen in psoriasis.
BACKGROUND:Psoriasis is a chronic immune-mediated inflammatory skin disease associated with increase of some pro-inflammatory mediators. We wanted to investigate whether there is a relationship between psoriasis and visfatin, fetuin-A and pentraxin 3 (PTX3)-pro-inflammatory mediators implicated in the development of insulin resistance (IR), metabolic syndrome, and atherosclerosis. METHODS:Visfatin, fetuin-A, and PTX3 concentrations were measured in 45 patients with plaque-type psoriasis and 45 healthy controls using enzyme-linked immunosorbent assay (ELISA). RESULTS: Serum levels of visfatin, fetuin-A, and PTX3 in patients with psoriasis were found to be higher than in healthy controls (P = 0.002, P = 0.009, P < 0.001, respectively). Psoriasis area and severity index (PASI) score correlated significantly with visfatin and fetuin-A levels (P = 0.011, P = 0.040, respectively). There was a significant positive correlation between visfatin and fetuin-A (P < 0.001). PTX3 levels were correlated positively with homeostasis model assessment (HOMA-IR), insulin, triglyceride (TG), and very low density lipoprotein cholesterol (VLDL; P = 0.009, P = 0.007, P = 0.023, P = 0.024, respectively). CONCLUSIONS: Increased serum visfatin, fetuin-A, and PTX3 levels, and the presence of positive correlation between visfatin, fetuin-A, and PASI score, probably reflect the inflammatory state and IR seen in psoriasis.
Authors: S Boehncke; D Thaci; H Beschmann; R J Ludwig; H Ackermann; K Badenhoop; W-H Boehncke Journal: Br J Dermatol Date: 2007-10-04 Impact factor: 9.302
Authors: Monica Salvi; Laura Macaluso; Cecilia Luci; Carlo Mattozzi; Giovanni Paolino; Yvonne Aprea; Stefano Calvieri; Antonio Giovanni Richetta Journal: World J Clin Cases Date: 2016-02-16 Impact factor: 1.337
Authors: Gia Deyab; Ingrid Hokstad; Jon Elling Whist; Milada Cvancarova Småstuen; Stefan Agewall; Torstein Lyberg; Barbara Bottazzi; Pier Luigi Meroni; Roberto Leone; Gunnbjorg Hjeltnes; Ivana Hollan Journal: PLoS One Date: 2017-02-22 Impact factor: 3.240
Authors: Sindre Lee-Ødegård; Thor Ueland; Per M Thorsby; Pål Aukrust; Annika E Michelsen; Bente Halvorsen; Christian A Drevon; Kåre I Birkeland Journal: BMC Endocr Disord Date: 2022-08-17 Impact factor: 3.263
Authors: Hanan Hassan Sabry; Jehan Hassan Sabry; Aliaa El Husseiny Daifalla; Essam Mohamed Akl; Ahmed Mohamed Hamed; Ahmed Abd Allah Torky Journal: Vasc Health Risk Manag Date: 2018-07-09